CRISPR Therapeutics AG (CRSP) Treasury Shares (2016 - 2026)
CRISPR Therapeutics AG's Treasury Shares was $60,000 in Q2 2026, down 3.2% from $62,000 a year earlier and unchanged from the prior quarter.
Analysis
CRISPR Therapeutics AG (CRSP) Treasury Shares (2016 - 2026) Analysis & Trends
From Q2 2018 onward, CRISPR Therapeutics AG has reported Treasury Shares for 33 quarters.
- Treasury Shares shows a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- In earlier years, Treasury Shares was $62,000 in FY2024 (unchanged), $62,000 in FY2023 (-1.6%), $63,000 in FY2022 (unchanged) and $63,000 in FY2021 (unchanged).
- Quarterly Treasury Shares has moved between $60,000 (Q3 2025) and $63,000 (Q3 2023) over five years.
- Compared with a year earlier, Treasury Shares has declined for four straight quarters, with an average decline of 1.8% over the last eight quarters.
- Across the past five years, year-over-year decline in Treasury Shares ran from 0.0% in Q2 2025 to 3.2% in Q3 2025.
- Per Business Quant data, CRSP's Treasury Shares in the three quarters before Q2 2026 was $60,000 (Q1 2026), $60,000 (Q4 2025) and $60,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 711.62 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 77.11 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.11 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 49.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 3.94 Bn |
| 10 | CRISPR Therapeutics AG | 4.88 Bn | -3.82 Bn | - | 100,316.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100,316.00 |
| Mar 31, 2026 | 115,316.00 |
| Dec 31, 2025 | 115,316.00 |
| Sep 30, 2025 | 125,316.00 |
| Jun 30, 2025 | 170,316.00 |
| Mar 31, 2025 | 170,316.00 |
| Dec 31, 2024 | 170,316.00 |
| Sep 30, 2024 | 170,316.00 |
| Jun 30, 2024 | 170,316.00 |
| Mar 31, 2024 | 170,316.00 |
| Dec 31, 2023 | 170,316.00 |
| Sep 30, 2023 | 180,316.00 |
| Jun 30, 2023 | 180,316.00 |
| Mar 31, 2023 | 180,316.00 |
| Dec 31, 2022 | 180,316.00 |
| Sep 30, 2022 | 180,316.00 |
| Jun 30, 2022 | 180,316.00 |
| Mar 31, 2022 | 180,316.00 |
| Dec 31, 2021 | 180,316.00 |
| Sep 30, 2021 | 180,316.00 |
API Access
CRISPR Therapeutics AG Treasury Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=CRSP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();